DC Field | Value | Language |
---|---|---|
dc.contributor.author | Jung Hyun Shim | - |
dc.contributor.author | W A Choi | - |
dc.contributor.author | J W Kim | - |
dc.contributor.author | Hae Sook lee | - |
dc.contributor.author | Tae Woong Baek | - |
dc.contributor.author | Min Cheol Cho | - |
dc.contributor.author | Kyung-Ae Lee | - |
dc.contributor.author | B C Sang | - |
dc.contributor.author | Do Young Yoon | - |
dc.date.accessioned | 2017-04-19T09:00:17Z | - |
dc.date.available | 2017-04-19T09:00:17Z | - |
dc.date.issued | 2003 | - |
dc.identifier.issn | I000-0135 | - |
dc.identifier.uri | https://oak.kribb.re.kr/handle/201005/6243 | - |
dc.description.abstract | Background: β-1,3-glucans are well known to enhance the immune reactions, resulting in antitumor, antibacterial, antiviral, anticoagulatory and wound healing activities. β-1, 3-glucans have various activities depending on molecular weight, degree of branching, conformation, water-solubility and intermolecular association. However, the β-1,3-glucan linked backbone structure is essential and β-D-glucopyranosyl units are required for immuno-potentiating activities. Result: In this study, we tested the immunophamacological activities of soluble β-1,3-glucans and confirmed the following activities: (1) IFN-γ production in PBMCs in the presence or the absence of PHA, LPS, or IL-18; (2) induction of various cytokines in the spleen and thymus; (3) adjuvant effect on the antibody production; (4) nitrogen oxide synthesis in macrophages; (5) the cytotoxic and antitumor effects on cell lines and ICR mice. Conclusion: These results strongly suggested that β-1,3-glucans possessed various immuno-pharmacological activities. | - |
dc.publisher | Korea Soc-Assoc-Inst | - |
dc.title | Immune stimulating efficacy of soluble β-1,3-glucans = 수용성 β-1,3-glucans의 면역 활성 효능에 대한 연구 | - |
dc.title.alternative | Immune stimulating efficacy of soluble β-1,3-glucans | - |
dc.type | Article | - |
dc.citation.title | Immune Network | - |
dc.citation.number | 2 | - |
dc.citation.endPage | 163 | - |
dc.citation.startPage | 156 | - |
dc.citation.volume | 3 | - |
dc.contributor.affiliatedAuthor | Jung Hyun Shim | - |
dc.contributor.affiliatedAuthor | Hae Sook lee | - |
dc.contributor.affiliatedAuthor | Tae Woong Baek | - |
dc.contributor.affiliatedAuthor | Min Cheol Cho | - |
dc.contributor.affiliatedAuthor | Kyung-Ae Lee | - |
dc.contributor.affiliatedAuthor | Do Young Yoon | - |
dc.contributor.alternativeName | 심정현 | - |
dc.contributor.alternativeName | 최원아 | - |
dc.contributor.alternativeName | 김종완 | - |
dc.contributor.alternativeName | 이해숙 | - |
dc.contributor.alternativeName | 백태웅 | - |
dc.contributor.alternativeName | 조민철 | - |
dc.contributor.alternativeName | 이경애 | - |
dc.contributor.alternativeName | 상병찬 | - |
dc.contributor.alternativeName | 윤도영 | - |
dc.identifier.bibliographicCitation | Immune Network, vol. 3, no. 2, pp. 156-163 | - |
dc.identifier.doi | 10.4110/in.2003.3.2.156 | - |
dc.subject.keyword | soluble β-1,3-glucan | - |
dc.subject.keyword | immunophamacological activities | - |
dc.subject.keyword | antitumor effect | - |
dc.subject.local | soluble β-1,3-glucan | - |
dc.subject.local | immunophamacological activities | - |
dc.subject.local | immunopharmacological activities | - |
dc.subject.local | Anti-tumor effects | - |
dc.subject.local | Antitumor effect | - |
dc.subject.local | Antitumor effects | - |
dc.subject.local | antitumor effect | - |
dc.subject.local | antitumor effects | - |
dc.subject.local | Anti-tumor effect | - |
dc.description.journalClass | Y | - |
There are no files associated with this item.
Items in OpenAccess@KRIBB are protected by copyright, with all rights reserved, unless otherwise indicated.